SUMMARY
Growth of Bacteroides fragilis under anaerobic conditions in the presence of either haemin or protoporphyrin IX was inhibited by the ferrous iron chelator bipyridyl. The ferric-iron chelator desferrioxamine inhibited growth in the presence of protoporphyrin but not haemin, suggesting that even under anaerobic conditions Fe 3 + is involved in uptake of non-haem iron, which is required in the absence of haemin. However, the ferric iron chelators 1,2-dimethyl-3-hydroxy-pyrid-4-one (L1) and pyridoxal isonicotinoyl hydrazone (PIH) were only weakly inhibitory. Apotransferrin, which also binds Fe 3+, inhibited growth, but this was not simply due to binding of iron in the medium, as under the reducing conditions present, transferrin was unable to bind iron. This study suggests that even under anaerobic conditions, uptake of
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non-haem iron by B. fragilis may involve conversion of Fe 2+ to Fe 3+.
INTRODUCTION
Anaerobic bacteria are important human pathogens. In particular Bacteroides fragilis, although only a minor component of the human intestinal Bacteroides flora, is the species most frequently found in clinical infections [1] [2] [3] . The reasons for the differences in virulence between species of anaerobes are unclear, although certain factors such as microbial adherence, production of enzymes and toxins, and inhibition of phagocytosis may be important [4] . However, there are other factors which, although considered of importance in infections by aerobes, have been given little attention in the pathogenesis of anaerobic infections.
One such mechanism is the ability of bacteria to acquire iron from host tissues. Iron is essential for the growth of pathogens and growth of B. fragilis requires iron, which can be supplied ei-ther as haem or a combination of protoporphyrin IX and non-haem iron [5, 6] . Iron is not readily available in host tissues as under normal (aerobic) physiological conditions it is bound tightly to proteins such as transferrin, ferritin and haemoglobin [7] . Aerobic or facultative pathogens can overcome the effect of host iron-binding proteins by secreting high-affinity, low-molecular-mass iron chelators (siderophores), which scavenge host iron and are taken up via specific outer-membrane receptors [8, 9] . In contrast, it has generally been thought that such mechanisms would be less important for strictly anaerobic pathogens as iron will preferentially exist as the ferrous rather than the ferric form. Ferrous iron is not bound by transferrin [10] , and unlike ferric iron it can exist as a soluble low-molecular weight cation at neutral pH.
However, iron uptake by anaerobes has not been studied in great detail, and it has yet to be established that ferrous rather than ferric iron is actually taken up.
In this study we have investigated the relative availability of haem and non-haem iron to B. fragilis using a synthetic growth medium. We have also examined the oxidation state of nonhaem iron acquired by B. fragilis by studying the effect of transferrin and iron chelators on the availability of non-haem iron under anaerobic. conditions.
MATERIALS AND METHODS

Bacterial strain
The human enteropathogenic strain B. fragilis 20656-2-1 (kindly provided by Dr. L.L. Myers, Montana State University) was routinely subcultured on Wilkins-Chalgren anaerobe blood agar (Oxoid) containing 5% horse blood in anaerobic jars containing 85% N 2, 10% CO 2 and 5% H 2.
Medium preparation
Low-iron sterile plastic-ware, or glassware washed with 0.5 N HC1 overnight and rinsed three times with double-distilled water, were used throughout to reduce iron contamination. The minimal defined medium of Varel and Bryant [11] was used with the following modifications in the concentrations of certain components, (Dr. A. Speekenbrink, personal communication): KH 2 PO4, 1.15 g/l; CaCI 2. 2H20 , 6.6 mg/l; MnCI 2 . 4H20, 1 mg/l; cysteine-HCl, 763 mg/I and dithioerythritol, 250 mg/l. Haemin and FeSO 4 were omitted unless otherwise stated. The iron content of the medium was determined by atomic absorption spectroscopy and found to range from 0.27-0.75/xM depending upon the batch.
Materials
Haemin (Sigma, Poole, U.K.) was dissolved in 1 N NaOH and diluted 25-fold in water. The stock solution (4 mg/ml) was sterilised by autoclaving at 121°C for 15 rain. Protoporphyrin IX disodium salt (Sigma) was dissolved at 8 mg/ml in 2.7 N HCI in ethanol and diluted 1:2 with water. Transferrin (iron free) was obtained from Hoechst-Behring, Hounslow, U.K. Stock ferrous sulphate (8 mg/ml) was freshly prepared in 10 mM HCI. These solutions were sterilised by membrane filtration.
Desferrioxamine mesylate (Desferal; DFO) was obtained from Ciba-Geigy, Horsham, U.K. 1,2-Dimethyl-3-hydroxy-pyrid-4-one (L1) was kindly provided by Dr. G. Kontoghiorghes, Royal Free Hospital, London, UK, and pyridoxal isonicotinoyl hydrazone (PIH) by Dr. P. Ponka, McGill University, Montreal, Canada. L1 and PIH were dissolved in a few drops of warm 10 mM HC1 before making up to volume in saline. The ferrous iron chelator 2,2'-bipyridyl (BDH, Glasgow, UK) was dissolved in methanol and then diluted with an equal volume of water. The oxidation-reduction indicator resazurin (7-hydroxy-3H-phenoxazin-3-one 10 oxide, sodium salt) was obtained from Sigma and added to culture medium at 1 /xg/ml.
Determination of growth rate
B. fragilis was inoculated from a blood agar plate into the low-iron medium and subcultured three times before use. Growth was assessed by inoculating 10 ml of the medium (with appropriate additions) with 0.1 ml of overnight culture. Growth rates were estimated by nephelometry.
Determination of iron-binding by transferrin under anaerobic conditions
Apotransferrin (2 mg/ml) in 20 mM phosphate buffered saline containing 12 mM sodium bicarbonate, pH 7.2, was labelled overnight with [59Fe]-citrate (specific activity 10/xCi//xg, Amersham, U.K.) at 1 txCi/mg of protein giving a saturation of approximately 7%. The labelled transferrin was added to uninoculated medium under N 2 and incubated at 37 °C for 24 h. After this period the medium was ultrafiltered (Centricon 10; Amicon, Glos, U.K.) and the [59Fe] activity in the filtrate and retentate determined in a gamma-counter. Controls in air instead of N 2 or using PBS/NaHCO 3 instead of medium were treated similarly. The effect of cysteine, dithioerythritol and resazurin on iron-binding was also tested in a similar way.
RESULTS
Effect of haemin, protoporphyrin and iron on growth of Bacteroides fragilis
In the absence of haemin or protoporphyrin, B. fragilis was unable to grow, but protoporphyrin gave a dose-dependent enhancement of growth in low-iron medium ( dependence on protoporphyrin (data not shown).
Haemin also was stimulatory in a dose-dependent manner, but was less effective than protoporphyrin as 0.5 /zg/ml was required for maximum growth (Fig. 2) . Since growth in the presence of protoporphyrin requires non-haem iron [5, 6] , it is likely B. fragilis was using the endogenous nonhaem iron in medium supplemented with protoporphyrin. In both cases logarithmic growth occurred mainly between 8 and 16 h of incubation, with a less rapid increase in cell density thereafter.
Effect of iron chelators on growth of B. fragilis
To examine whether B. fragilis was using endogenous non-haem iron, the effect of iron chelators on growth was examined. The ferrous iron chelator bipyridyl had a dose-dependent inhibitory effect on the growth of B. fragilis either in the presence of haemin at 2 /zg/ml or protoporphyrin IX at 0.01/zg/ml ( Table 1 ). The effect could be largely abolished when bipyridyl was saturated with ferrous sulphate (data not showed). The ferric-iron chelator desferrioxamine (DFO) at 10 /zg/ml or more also significantly inhibited growth in the presence of protoporphyrin (Table  2) , but the hydroxypyridone ferric-iron chelator L1 was much less effective, as only partial inhibition was observed at 100 izg/ml, and almost none at 10 /zg/ml. PIH had an intermediate effect, there being moderate inhibition at 10/~g/ml and strong inhibition at 100 p~g/ml although by 48 h even this effect was largely overcome (data not shown). The inhibitory effect of DFO was lost when haemin (2 txg/ml) was used instead of protoporphyrin (Table 3) . This difference was not simply due to the larger amount of haemin re- 
Effect of transferrin
Since the ferric iron chelator DFO was able to inhibit growth of B. fragilis even under anaerobic conditions, it was of interest to determine whether transferrin, which also binds ferric iron, could inhibit growth. Apotransferrin at a concentration of 100 txg/ml (1.3 /xM) was able to inhibit B.
fragilis in the presence of protoporphyrin, but the effect was much reduced (though not completely abolished) when transferrin was saturated with iron (Table 4) . Since transferrin can only bind ferric iron, it is surprising that it had such a strong inhibitory effect on growth under anaerobic conditions. The ability of transferrin to bind iron under the conditions of growth was therefore examined. As shown in Fig. 3 , in the reduced culture medium used for growth of B. fragilis, iron was no longer bound by transferrin, although iron binding was largely restored when the medium was exposed to air. The inhibitory effect of transferrin on growth of B. fragilis cannot therefore be due to a simple scavenging of iron from the medium, as under the conditions of culture it cannot bind iron. Since the anaerobic conditions for growth of B. fragilis require addi- tion of reducing compounds and the anaerobiosis indicator resazurin to the medium, the relative importance of anaerobiosis and these agents in the loss of iron-binding capacity was examined. In the absence of these agents, or in the presence of resazurin only, transferrin was able to bind iron under anaerobic conditions. However, the presence of sulphydryl compounds (cysteine and dithioerythritol) resulted in iron being lost from transferrin. Thus, under anaerobic conditions transferrin was still able to bind iron but addition of sulphydryl compounds (as used in the culture medium) caused iron to be released.
DISCUSSION
Growth of B. fragilis could be stimulated by either haemin or protoporphyrin IX, in agreement with the reports of Sperry et al., [5] and Otto et al., [12] . The fact that a higher concentration of haemin than protoporphyrin was required may be due to the relative solubilities of the two compounds, and indeed the previous studies have reported widely varying optimal concentrations. Growth in the presence of protoporphyrin also requires a source of non-haem iron [5, 12] , which in this work was presumably provided by the endogenous iron in the medium. The ferrous iron chelator bipyridyl not only inhibited growth in the presence of protoporphyrin, but also in the presence of haemin, despite the fact that haem iron is 49 not accessible to chelators such as bipyridyl. There are two possible explanations for this observation. Iron may be released from haemin within the cell, and bipyridyl, which is known to enter cells (R. Hider, personal communication) chelates the resulting intracellular ferrous iron, resulting in interference with growth. Alternatively, a source of non-haem iron is required even in the presence of haemin, as suggested by Caldwell and Arcand [13] . Our results support the former proposal, as DFO, a ferric-iron chelator, inhibited growth in the presence of protoporphyrin but not in the presence of haemin. This makes it unlikely that an extracellular source of non-haem iron is required for growth in the presence of haemin, and also suggests that uptake of non-haem iron may involve ferric iron even under anaerobic conditions. Since B. fragilis apparently does not produce a siderophore [14] it may be that uptake of ferrous iron from the anaerobic environment occurs via an oxidation to Fe 3+, perhaps by a compound of the microbial surface, and it is then susceptible to chelation by DFO. Alternatively, DFO itself may have ferroxidase activity [15] , enabling it to oxidise ferrous iron to ferric iron, which it can then bind. The two other iron chelators tested, L1 and PIH, were less inhibitory than DFO, and the modest inhibitory effects may have been partly due to toxicity rather than iron chelation, as when iron complexes of these chelators were used their inhibitory effect was not reduced (data not shown). However, unlike DFO, the iron complexes of these chelators can enter cells [16, 17] and thus they may allow some extracellular non-haem iron to enter B. fragilis cells and support growth.
Further evidence that uptake of non-haem iron under anaerobic conditions nevertheless involves Fe 3+ comes from the results showing that apotransferrin inhibited growth of B. fragilis. This cannot be simply due to binding of iron in the medium, as under the reducing conditions present, transferrin could not bind iron, a result which agrees with Kojima and Bates [18] who showed that reducing agents such as dithionite can remove iron from transferrin at physiological pH. Interference with uptake of Fe 3+ at the cell surface, as proposed above, could also explain the action of transferrin. Alternatively, it may act by damaging the outer membrane as a result of interaction with other cations, as suggested by Ellison et al. [19] .
Thus this study suggests that iron uptake by B.
fragilis does not involve simply a requirement for haem-iron or free Fe 2+. It provides evidence that iron may be removed from haem intracellularly, and that even under anaerobic conditions, uptake of non-haem iron may involve conversion of Fe z+ to Fe 3+.
